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ABSTRACT 
CENTRAL OBESITY IN THE PRESENCE OF METABOLIC SYNDROME 
HAS ENHANCED OXIDATIVE STRESS 
Azlina AR, Taib R, Sayyedah N, Muid S, Osman M, Yusoff K, Ismail T, Nawawi H 
Faculty of Medicine, Universiti Teknologi MARA, Shah Alam 
Background: Metabolic syndrome (MS) is a cluster of abdominal obesity, 
atherogenic dyslipidaemia, hypertension and insulin resistance with or without 
hyperglycaemia associated with increased risk of coronary heart diseases. There may 
be a possible link between MS, central obesity and increased markers of oxidative 
stress. The oxidative stress in central obesity and MS with different glycaemic status 
is still unclear. 
Objective: The aim of our study was to evaluate the oxidative stress in central 
obesity and MS subjects with different glycaemic status and subjects with central 
obesity without MS. 
Design: A total of 260 subjects (Mean±SD : 53±11, 66 Males) were randomly 
recruited and divided into 5 groups: central obesity without MS (OBXMS), MS with 
diabetes (MSDM), MS with impaired fasting glucose (MSIFG), MS with 
normoglycaemia (MSNG) and normal control (NC). In addition, MSDM, MSIFG 
and MSNG were grouped as all MS group with a total number of 156. The blood 
levels of oxidized low-density lipoprotein (oxLDL) and 8-Isoprostane were 
evaluated. 
Results: OBXMS group was not significantly different compared to NC group. 
MSDM group compared to NC group had higher 8-Isoprostane (pO.OOl). MSIFG 
group compared to NC group had higher oxLDL (p<0.05) and 8-Isoprostane 
(pO.OOl). MSNG group compared to NC group had higher 8-Isoprostane (pO.OOl). 
All MS group compared to NC group had higher oxLDL (p<0.05) and 8-Isoprostane 
(pO.OOl). All MS group compared to OBXMS group had higher 8-Isoprostane 
(pO.OOl). 
Conclusions: MS irrespective of glycaemic status has enhanced oxidative stress 
compared to controls. There is enhanced oxidative stress in central obesity especially 
in the presence of MS, suggesting high coronary risk of MS subjects. 
Presented at Annual Scientific Meeting of Australian Atherosclerosis Society, 13-16 
October, 2009. 
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1.0 INTRODUCTION AND BACKGROUND 
1.1 Introduction & General Background 
Metabolic syndrome (MS) has multiple, interrelated factors that raise risk and is 
characterized by a constellation of metabolic risk factors within an individual. This 
cluster of disorders is collectively called the metabolic syndrome - a term 
synonymous with syndrome X, insulin-resistance syndrome, plurimetabolic 
syndrome and Reaven's syndrome (Betteridge, 2004). Specifically, this includes 
abdominal obesity, high blood pressure (BP), high triglycerides (TG), high low 
density lipoprotein cholesterol (LDL-c), hyperglycaemia, and diabetes mellitus (DM) 
as well as the insulin resistance which is the main candidate for being the underlying 
etiology (Isomaa et ai, 2001). The mechanistic connections between insulin 
resistance and metabolic risk factors are not fully understood and appear to be 
complex (Zainal Arifin et ai9 2005). 
Clustering analysis has shown that risk factors for diabetes and cardiovascular 
disease (CVD) are more likely to occur simultaneously than would be expected by 
chance, suggesting that they underlie the same metabolic disorders (Betteridge, 
2004). It has been suggested that increased oxidative stress as an early event in the 
development of the MS and, as such, might contribute to disease progression 
(Goldstein and Scalia, 2004). 
Oxidative stress is defined as the imbalance in the rate at which the intracellular 
content of free radicals, produced through a number of cellular events, increases 
relative to the capacity of the cell to dispose of these oxidants. When not neutralized, 
these free radicals have the capacity to alter the integrity of numerous molecules such 
as lipids, proteins and DNA (Goldstein and Scalia, 2004). 
Lipids are the major target of free radical attack, which induces lipid peroxidation. 
Free radical-induced peroxidation of membrane lipids can be very damaging because 
it leads to alterations in the biophysical properties of the membrane, such as the 
degree of fluidity, and can lead to inactivation of membrane-bound receptors or 
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